IL7R
protein-codinginterleukin 7 receptor, the group of CD molecules|Interleukin receptors|Fibronectin type III domain containing
Gene summary
The protein encoded by this gene is a receptor for interleukin 7 (IL7). The function of this receptor requires the interleukin 2 receptor, gamma chain (IL2RG), which is a common gamma chain shared by the receptors of various cytokines, including interleukins 2, 4, 7, 9, and 15. This protein has been shown to play a critical role in V(D)J recombination during lymphocyte development. Defects in this gene may be associated with severe combined immunodeficiency (SCID). Alternatively spliced transcript variants have been found. [provided by RefSeq, Dec 2015]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~26.9 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0012163
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0011338
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0015701
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0012163
Submitter: ClinGen
IL7R was first reported in relation to autosomal recessive severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, NK cell-positive in 1998 (PMID: 9843216). IL7R encodes a receptor for interleukin-7, a glycoprotein which is involved in lymphopoiesis regulation and is essential for the development of T cells. Nine variants (missense, splicing, nonsense, and frameshift) that have been reported in six probands in six publications (PMID: 11023514, 9843216, 19890784, 30778343, 15615257, 26123418) are included in this curation. Variants in this gene segregated with disease in two additional family members. Heterozygous parents and other relatives were unaffected in all reported families. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. The mechanism of pathogenicity is known to be loss of function. This gene-disease association is also supported by expression studies showing that IL7R is expressed in murine B and T cell lineages (PMID: 8415665) and IL7R expression is severely decreased to absent in patients with T-B+NK+ SCID (PMID: 9843216). In addition, IL7R interacts with JAK3, which is also associated with a SCID phenotype (PMID: 17554063) and IL7R null mice have a phenotype consistent with T cell lymphopenia (PMID: 8692964, 7964471). T and B cell deficiency is rescued in IL7Ra deficient mice through introduction of IL7Ra by retroviral transfection (PMID: 16208423). In summary, IL7R is definitively associated with autosomal recessive severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, NK cell-positive. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen (SCID-CID) GCEP on 2/18/2021 (SOP Version 8).
Inheritance Pattern: AR
Disease ID:MONDO:0012163
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0012163
Submitter: Ambry Genetics
Clinical Genomic Database (CGD)
Manifestation: Allergy/Immunology/Infectious
Intervention: Allergy/Immunology/Infectious
Rationale: Individuals are susceptible to frequent and severe bacterial, viral, fungal, and opportunistic infections, and antiinfectious prophylaxis and early and aggressive treatment of infections may be beneficial; HSCT has been described
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to IL7R variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_002185.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 5 | 140 | 2 | 148 | |
| missense | 4 | 4 | 169 | 19 | 6 | 202 |
| nonsense | 7 | 13 | 1 | 21 | ||
| start loss | 1 | 1 | ||||
| frameshift | 19 | 5 | 2 | 26 | ||
| splice donor/acceptor (+/-2bp) | 9 | 2 | 1 | 1 | 13 | |
| Total | 40 | 25 | 178 | 160 | 8 | 411 |
Highest pathogenic variant AF is 0.0012724089
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_002176.2 | 8 | MANE Select | |
| Ensembl | ENSP00000306157.3 | 8 | MANE Select | |
| RefSeq | NP_001397663.1 | 7 | Standard | |
| RefSeq | NP_001424892.1 | 6 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| il7r | Danio rerio | Structure: pro-T cell Quality: decreased amount abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- PI3K-Akt signaling pathway - Homo sapiens (human)
- Primary immunodeficiency - Homo sapiens (human)
- Jak-STAT signaling pathway - Homo sapiens (human)
- FoxO signaling pathway - Homo sapiens (human)
- Pathways in cancer - Homo sapiens (human)
Biological Process
- regulation of DNA recombination
- cell morphogenesis
- negative regulation of T cell mediated cytotoxicity
- immunoglobulin production
- immune response
Molecular Function
- antigen binding
- cytokine receptor activity
- interleukin-7 receptor activity
- protein binding
Cellular Component
- extracellular region
- plasma membrane
- external side of plasma membrane
- integral component of membrane
- clathrin-coated vesicle membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000303115
- Coding exons
- 8
- Length
- 26909
- Individuals with no LoFs
- 125678
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 58
- Defined
- 125736
- p
- 0.000231
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -1.29 | 288 | 233 | 1.24 | 0.0000115 | 3020 |
| Missense (PolyPhen) | 68 | 62.246 | 1.0924 | 877 | ||
| Synonymous | -0.552 | 98 | 91.3 | 1.07 | 0.00000477 | 865 |
| Loss of Function | 1.43 | 13 | 19.9 | 0.654 | 9.26e-7 | 263 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00031 | 0.00031 | rare |
| Latino/Admixed American | 0.00017 | 0.00017 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00027 | 0.00027 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.00033 | 0.00033 | rare |
| South Asian | 0.00013 | 0.00013 | rare |
| Other | 0.00016 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Receptor for interleukin-7. Also acts as a receptor for thymic stromal lymphopoietin (TSLP).;
- Disease
- DISEASE: Severe combined immunodeficiency autosomal recessive T- cell-negative/B-cell-positive/NK-cell-positive (T(-)B(+)NK(+) SCID) [MIM:608971]: A form of severe combined immunodeficiency (SCID), a genetically and clinically heterogeneous group of rare congenital disorders characterized by impairment of both humoral and cell-mediated immunity, leukopenia, and low or absent antibody levels. Patients present in infancy recurrent, persistent infections by opportunistic organisms. The common characteristic of all types of SCID is absence of T-cell-mediated cellular immunity due to a defect in T-cell development. {ECO:0000269|PubMed:11023514, ECO:0000269|PubMed:9843216}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Multiple sclerosis 3 (MS3) [MIM:612595]: A multifactorial, inflammatory, demyelinating disease of the central nervous system. Sclerotic lesions are characterized by perivascular infiltration of monocytes and lymphocytes and appear as indurated areas in pathologic specimens (sclerosis in plaques). The pathological mechanism is regarded as an autoimmune attack of the myelin sheath, mediated by both cellular and humoral immunity. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia and bladder dysfunction. Genetic and environmental factors influence susceptibility to the disease. {ECO:0000269|PubMed:17660817}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. A polymorphism at position 244 strongly influences susceptibility to multiple sclerosis. Overtransmission of the major 'C' allele coding for Thr-244 is detected in offspring affected with multiple sclerosis. In vitro analysis of transcripts from minigenes containing either 'C' allele (Thr-244) or 'T' allele (Ile-244) shows that the 'C' allele results in an approximately two-fold increase in the skipping of exon 6, leading to increased production of a soluble form of IL7R. Thus, the multiple sclerosis associated 'C' risk allele of IL7R would probably decrease membrane-bound expression of IL7R. As this risk allele is common in the general population, some additional triggers are probably required for the development and progression of MS.;
Recessive Scores
- pRec
- 0.580
Intolerance Scores
- LoFtool
- 0.563
- RVIS EVS
- 0.93
- RVIS percentile EVS
- 89.83
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.646
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |